Forbes @Forbes
If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA https://t.co/UIF6GCrQfM — PolitiTweet.org
Created
Fri Jan 14 11:10:01 +0000 2022
Likes
35
Retweets
9
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Forbes @Forbes
If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA https://t.co/UIF6GCrQfM — PolitiTweet.org